Global Macrolide Antibiotics Market 2018-2023: Growing with Merck Sharp & Dohme Co., Pfizer Inc., Mylan N.V. and Others

The Global Macrolide Antibiotics Market is expected to grow at a CAGR of 12.5% during the forecast period from 2017-2023.

Macrolide Antibiotics Market - Major Players

Some of the key players in the global market are:

Merck Sharp & Dohme Corp (U.S.)
Pfizer Inc. (U.S.)
Neo Química (Brazil)
Macrolide Pharmaceuticals (U.S.)
Teva Pharmaceutical Industries Ltd.(Israel)
Fresenius Kabi USA (U.S.)
Sandoz International GmbH (Germany)
Gland Pharma Limited (India)
Mylan N.V. (U.S.)
WOCKHARDT (U.S.)

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4342 .

Macrolide Antibiotics Market – Segmentation

The Global Macrolide Antibiotics Market is segmented on the basis of drugs, which includes azithromycin, clarithromycin, erythromycin, fidaxomicin, and telithromycin. On the basis of route of administration, the market is segmented into oral, parenteral. On the basis of indication, the market is segmented into infection due to mycoplasma pneumoniae, legionella sp, or bordetella pertussis, symptomatic cat-scratch disease, bacillary angiomatosis, peliosis hepatis in patients with AIDS, cerebral toxoplasmosis, uncomplicated skin infections, and others. On the basis of end user, the market is segmented into hospitals, dermatology clinics, pharmaceutical companies, and others.

Macrolide Antibiotics Market - Overview

Macrolides such as azithromycin, clarithromycin, and erythromycin are a class of antibiotics that inhibit protein synthesis. It acts as a bacteriostatic agent against many strains of corynebacteria, listeria, moxicella, streptococci, Neisseria meningitides, Staphylococci, Clostridia, and Haemophilus sp. It is used for the treatment of bacterial infections, such as nose, ear, and throat infections, chest infections, skin infections as well as mouth and dental infections. They are also used as an alternative to penicillin. The Global Macrolide Antibiotics Market is expected to grow at a CAGR of 12.5% during the forecast period 2017-2023.

Macrolides are a class of antibiotics derived from Saccharopolyspora erythraea. They inhibit protein synthesis in bacteria by binding to the 50S ribosomal element and effective against gram positive bacteria and intracellular pathogens such as Legionella, Mycoplasma, and Chlamydia. It primarily act as a bacteriostatic agent against many strains of Corynebacteria, Listeria, Moxicella, Streptococci, Neisseria meningitides, Staphylococci, Clostridia, and Haemophilus sp.

The market of macrolide antibiotics exhibits a significant growth across the globe owing to the increasing prevalence of skin infections and growing demand for drugs against bacterial skin infections.

Major concerns involved in the use of macrolide antibiotics are GI disturbances and inhibition of hepatic metabolism. According to a study published in the Journal of the American College of Cardiology, macrolide antibiotics may increase the risk of sudden cardiac death, ventricular tachyarrhythmias, and cardiovascular death in patients, which may hinder the growth of the market over the review period.

The Global Macrolide Antibiotics Market is expected to show a sharp growth over the forecast period owing to an increasing demand for macrolide across the globe. Rising prevalence of bacterial skin infections and rising number of dermatology clinics also favor the market growth. According to a study published in the Journal of the American College of Cardiology, macrolide antibiotics may increase the risk of sudden cardiac death, ventricular tachyarrhythmias, and cardiovascular death in patients, which may hinder the growth of the market over the assessment period.

Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/4342 .

The market of macrolide antibiotics exhibits a significant growth across the globe owing to the increasing prevalence of skin infections and growing demand for drugs against bacterial skin infections. Major concerns involved in the use of macrolide antibiotics are GI disturbances and inhibition of hepatic metabolism. According to a study published in the Journal of the American College of Cardiology, macrolide antibiotics may increase the risk of sudden cardiac death, ventricular tachyarrhythmias, and cardiovascular death in patients, which may hinder the growth of the market over the review period.

Macrolide Antibiotics Market - Regional Analysis

The global macrolide antibiotics market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominates the global macrolide antibiotics market. It comprises of two regions namely North America and South America. The market in the American region is driven by the rising prescription of antibiotics in out-patient department in the U.S.

In Europe, increasing use of azithromycin, and erythromycin has led to the rise in the demand for the macrolide antibiotics. France accounts for the largest market share followed by Germany owing to the increasing incidence of skin diseases.

Asia Pacific is the fastest growing and potential market for the macrolide antibiotics whose growth is attributed to the increasing awareness about the use of macrolides for the treatment various rare skin diseases and its side effects. Expansion of healthcare system in developing countries in Asia Pacific also favors the market growth.

The Middle East & Africa is expected to witness a steady growth in this market.

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

Continued….

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/4342 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.